Suarez-Almazor M E, Gonzalez-Lopez L, Gamez-Nava J I, Belseck E, Kendall C J, Davis P
Healthcare Quality and Outcomes Research Centre, the Department of Public Health Sciences, University of Alberta, Edmonton, Canada.
J Rheumatol. 1998 Oct;25(10):1980-5.
Antinuclear antibodies (ANA), rheumatoid factors (RF), and erythrocyte sedimentation rate (ESR) are among the most frequently requested tests in the diagnosis and investigation of connective tissue diseases (CTD). We evaluate the utilization patterns and predictive value of these tests in patients referred to rheumatologists by primary care physicians.
We reviewed the records of all new patients referred by primary care physicians in 1994 to 2 rheumatologists practicing at the University of Alberta. Data extracted from the records included diagnostic tests requested by referring primary care physicians, signs and symptoms at the initial rheumatology consult, and followup diagnoses.
Seven hundred eleven new patients had been referred by over 300 primary care physicians: RF had been requested in 25%, ANA in 21%, and ESR in 29%. One hundred nine (15%) of the 711 patients had a CTD, 45 (6%) had rheumatoid arthritis (RA), and 8 (1%) systemic lupus erythematosus (SLE). The predictive values of positive tests for the diagnosis of CTD were low: 49% for RF, 29% for ANA, and 35% for ESR. For RA, the positive predictive values were 44% for RF, 8% for ANA, 17% for ESR; for SLE, 2, 12, and 3%, respectively. Diffuse musculoskeletal pain and fatigue were significantly associated with test utilization, although most patients with these symptoms had fibromyalgia or localized soft tissue rheumatism.
Primary care physicians frequently requested autoantibodies in patients referred to rheumatologists. Most tests were negative, and were often requested in patients without CTD, resulting in low positive predictive values and questionable clinical utility. These findings suggest inappropriate overuse and lack of understanding of the use of autoantibody tests in diagnosing rheumatic diseases. A decrease in inappropriate use could be achieved by emphasizing that fatigue and diffuse musculoskeletal pain are not indicative of CTD in the absence of other features such as joint swelling, typical rash, or organ involvement.
抗核抗体(ANA)、类风湿因子(RF)和红细胞沉降率(ESR)是结缔组织病(CTD)诊断和检查中最常要求进行的检测项目。我们评估了这些检测在初级保健医生转诊给风湿病学家的患者中的使用模式和预测价值。
我们回顾了1994年由初级保健医生转诊给在阿尔伯塔大学执业的2名风湿病学家的所有新患者的记录。从记录中提取的数据包括转诊的初级保健医生要求的诊断检测、初次风湿病会诊时的体征和症状以及随访诊断。
300多名初级保健医生转诊了711名新患者:25%的患者要求检测RF,21%的患者要求检测ANA,29%的患者要求检测ESR。711名患者中有109名(15%)患有CTD,45名(6%)患有类风湿关节炎(RA),8名(1%)患有系统性红斑狼疮(SLE)。检测阳性对CTD诊断的预测价值较低:RF为49%,ANA为29%,ESR为35%。对于RA,RF的阳性预测值为44%,ANA为8%,ESR为17%;对于SLE,分别为2%、12%和3%。弥漫性肌肉骨骼疼痛和疲劳与检测的使用显著相关,尽管大多数有这些症状的患者患有纤维肌痛或局限性软组织风湿病。
初级保健医生经常在转诊给风湿病学家的患者中要求进行自身抗体检测。大多数检测结果为阴性,并且经常在没有CTD的患者中要求进行检测,导致阳性预测值较低且临床实用性存疑。这些发现表明在诊断风湿性疾病时存在不适当的过度使用和对自身抗体检测使用的理解不足。通过强调在没有关节肿胀、典型皮疹或器官受累等其他特征的情况下,疲劳和弥漫性肌肉骨骼疼痛并不提示CTD,可以减少不适当的使用。